Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

Stopped The trial is closing due to findings from a related study, prompting the sponsor to discontinue development and end this study.

Conditions

• Microsatellite Stable Metastatic Colorectal Cancer
• Metastatic Colorectal Cancer
• Colorectal Cancer

Interventions

• BIOLOGICAL: Tiragolumab
• BIOLOGICAL: Atezolizumab
• RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

National Cancer Institute (NCI)